Bristol Myers says Opdivo performs well in kidney, lung cancer trials
Opdivo is one of Bristol’s top-selling drugs, but sales of the drug have slowed in recent years as it has been eclipsed by Merck…
Author
Novartis to test efficacy of old malaria drug against COVID-19
The company hopes to have data on its efficacy by June, a lead researcher for the trial told Reuters
Institutional investors tell Big Pharma to cooperate on coronavirus
The investor group plan to send pharma companies a list of principles it wants them to abide by for the coming year…
Report says COVID-19 patients respond to Gilead’s remdesivir
A medical news website reported that UChicago Medicine recruited 113 people with severe COVID-19 into Gilead’s trial. It said most…
FDA may have dropped standards too far in hunt for chloroquine to fight coronavirus: Sources
Bayer has donated three million tablets of the drug, called Resochin, to the US national stockpile for treatment of COVID-19.…
The world will need more than one COVID-19 vaccine, says GSK CEO
Emma Walmsley, CEO, GlaxoSmithKline , said GSK's partnership with Sanofi brings scale to the attempt to get a COVID-19 vaccine but…
India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19
New Delhi had last month put a hold on exports of hydroxychloroquine (HCQ) to secure supplies for itself, before agreeing this…
EU to host May 4 donor conference for coronavirus vaccine search
"To support this global initiative, funding is needed,” Ursula Von der Leyen, President, European Commission, told a joint news…
Alnylam’s gene-silencing efforts get $2 billion Blackstone backing
Alnylam is the first drugmaker to win US approval for a treatment using the Nobel prize-winning RNA interference (RNAi) technology…
China approves two experimental coronavirus vaccines to enter clinical trials
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech , and by the Wuhan Institute of…